You are here
Phenotyping Steering Group
The Phenotyping Steering Group plays a role in assessing and developing phenotyping approaches within the IMPC pipeline
, including:
- Establishing a series of technical meetings to look at how tests are working, baseline data and phenotypes detected.
- Developing the IMPC Business Plan with respect to future phenotyping developments.
| Name | Institute |
|---|---|
| Karen Svenson* | The Jackson Laboratory |
| Yann Herault* | Institut Clinique de la Souris |
| Ann Flenniken | Toronto Centre for Phenogenomics |
| Corey Reynolds | Baylor College of Medicine |
| David West | Children's Hospital Oakland Research Institute |
| Jacqui White | The Wellcome Trust Sanger Institute |
| Je Kyung Seong | Korea Mouse Phenotyping Consortium |
| Mark Henkelman | Toronto Centre for Phenogenomics |
| Mohammed Selloum | Institut Clinique de la Souris |
| Monica Justice | Baylor College of Medicine |
| Nick Gale | Regeneron |
| Sara Wells | Medical Research Council Harwell |
| Shigeharu Wakana | RIKEN BioResource Centre |
| Tania Sorg-Guss | Institut Clinique de la Souris |
| Valerie Gailus-Durner | Helmholtz Zentrum Muenchen/Infrafrontier |
| *Committee co-chairs |
